HIV

J&J warns doctors not to count on Prezista as a COVID-19 treatment
Fierce Pharma
Tue, 03/17/20 - 12:06 pm
COVID-19
coronaviruses
Prezista
HIV
JNJ
ViiV, UNC-Chapel Hill renew HIV partnership for another five years
Pharma Times
Wed, 03/11/20 - 07:29 pm
HIV
ViiV
UNC-Chapel Hill
AbbVie to Test HIV Drug as a Potential Coronavirus Treatment
Motley Fool
Tue, 03/10/20 - 11:03 am
AbbVie
Kaletra
COVID-19
coronaviruses
HIV
Gilead's Descovy not worth the higher price over forthcoming Truvada generics: study
Fierce Pharma
Tue, 03/10/20 - 10:50 am
Gilead Sciences
Descovy
Truvada
HIV
drug pricing
GSK's ViiV touts 2-month HIV data as sister injection Cabenuva awaits FDA redemption
Fierce Pharma
Mon, 03/9/20 - 10:39 am
HIV
FDA
GSK
Cabenuva
ViiV
Where Will Gilead Sciences Be in 10 Years?
Motley Fool
Sat, 02/22/20 - 11:23 pm
Gilead Sciences
HIV
hepatitis C
Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court
Fierce Pharma
Fri, 02/21/20 - 10:39 am
Gilead Sciences
PrEP
HHS
patents
HIV
GBT takes a page from HIV playbook as it embarks on Oxbryta launch
Fierce Pharma
Thu, 02/13/20 - 11:31 pm
Global Blood Therapeutics
drug launches
Oxbryta
sickle cell disease
HIV
Gilead loses first PrEP patent challenge but vows to defend against HHS lawsuit
Fierce Pharma
Fri, 02/7/20 - 10:38 am
Gilead Sciences
HHS
HIV
patents
PrEP
Truvada
US cancels trial after finding vaccine doesn't prevent HIV
BioPharma Dive
Mon, 02/3/20 - 11:43 pm
South Africa
NIH
vaccines
HIV
FDA Launches PEPFAR Drug Database
RAPS.org
Thu, 01/30/20 - 09:32 pm
FDA
PEPFAR
AIDS
HIV
I Have a Dream… Five Dreams for Biotech
BioSpace
Mon, 01/20/20 - 11:03 am
biotech
patients
Alzheimer's disease
ALS
HIV
cancer
drug pricing
ViiV’s two-drug HIV therapy Dovato gets Japanese approval
Pharmaforum
Thu, 01/16/20 - 11:02 pm
ViiV Healthcare
Dovato
HIV
Japan
ViiV files first-in-class HIV drug in Europe
Pharmaforum
Mon, 01/13/20 - 10:23 am
ViiV Healthcare
Europe
HIV
fostemsavir
GSK's plan to take over the HIV drug market hasn't worked out
BioPharma Dive
Mon, 01/6/20 - 11:47 pm
GSK
FDA
HIV
Dovato
Biktarvy
ViiV Healthcare
Gilead Sciences
FDA slams GSK's monthly HIV injectable with CRL, citing manufacturing issues
Endpoints
Mon, 12/23/19 - 11:44 pm
FDA
complete response letter
GSK
HIV
cabotegravir
rilpivirine
GSK's ViiV seeks marketing license for baby-friendly HIV pill
Reuters
Sun, 12/15/19 - 12:23 am
GSK
HIV
Dolutegravir
pediatric
HHS Pays For PrEP But Who Will Prescribe It?
Forbes
Sat, 12/7/19 - 11:51 pm
HHS
HIV
PrEP
Ready Set PrEP
ViiV presses go on FDA filing for first-in-class HIV drug fostemsavir
Pharmaforum
Fri, 12/6/19 - 10:02 am
ViiV Healthcare
HIV
fostemsavir
FDA
Activists seek to block a Gilead patent extension on a lucrative HIV drug
Stat
Fri, 12/6/19 - 09:52 am
Gilead Sciences
patents
HIV
activists
TAF

Pages